Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Jonathan Violin > Profile

Jonathan Violin

Affiliations

  • Director at Astria Therapeutics Inc. (ATXS), 2025-06-12
  • at Dianthus Therapeutics Inc. (DNTH), 2025-05-22
  • Chief Executive Officer at Viridian Therapeutics Inc. (VRDN), 2023-02-07
  • Svp-Scientific Affairs & Ir at Trevena Inc (TRVN), 2018-03-02
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
VRDN $36.80 50,000 $1,840,000.00 480,905 2023-02-02 Filing
VRDN $36.80 50,000 $1,840,000.00 430,905 2023-02-02 Filing
VRDN $12.20 30,000 $366,000.00 480,905 2022-06-01 Filing
VRDN $13.04 30,000 $391,200.00 510,905 2022-05-02 Filing
VRDN $18.93 3,600 $68,148.00 540,905 2022-04-04 Filing